Welcome to our dedicated page for Petco Health & Wellness Company SEC filings (Ticker: WOOF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Petco Health and Wellness Company, Inc. filings document the formal disclosures of a pet specialty retailer with Class A common stock listed on Nasdaq under WOOF. Its Form 8-K reports cover operating results, earnings presentations, Regulation FD updates, fiscal outlooks and material events tied to the company's retail, services and digital pet-care business.
Petco's regulatory record also includes capital-structure disclosures for credit agreement amendments, term loan refinancing, senior secured notes due 2031, subsidiary guarantees and collateral priorities. Governance filings document board leadership changes and related compensatory arrangements, while exhibit filings preserve press releases, agreements and other materials incorporated into the company's public record.
Petco Health and Wellness Company (WOOF) reported mixed quarterly results with revenue modestly down while profitability improved. Net sales decreased from $1.52 billion to $1.49 billion, a 2.3% decline, with comparable sales down 1.4%. Operating income rose to $43.0 million from $2.5 million a year earlier, and net income attributable to Class A and B-1 stockholders turned positive at $14.0 million versus a $24.8 million loss previously. Adjusted EBITDA increased from $83.5 million to $113.9 million. The company noted impairment charges on fixed and right-of-use assets totaling $3.4 million and $6.9 million for the thirteen and twenty-six week periods ended August 3, 2024. The ABL Revolving Credit Facility capacity is described at $581.0 million and borrowing costs reference base rate (1% floor) or Term SOFR (0% floor) plus margins of 25 bps or 125 bps. Cash equivalents included restricted money market balances of $1.0 million and $15.6 million at two reported dates.
Petco Health and Wellness Company, Inc. filed a current report to furnish a press release with its financial results for the quarter ended August 2, 2025. The press release, dated August 28, 2025, is included as Exhibit 99.1.
The company scheduled a webcast at 4:30 p.m. Eastern Time on August 28, 2025 to discuss these quarterly results, with an accompanying earnings presentation and a replay to be made available on its investor relations website. The information under Items 2.02 and 7.01, including Exhibit 99.1, is being furnished rather than filed under the Exchange Act and is not automatically incorporated into other Securities Act or Exchange Act filings.
Petco Health and Wellness Company, Inc. filed a current report to share that it will participate in the 32nd Annual Goldman Sachs Global Retailing Conference. The presentation is scheduled for September 4, 2025 at approximately 1:50 p.m. Eastern Time.
A live webcast of Petco’s presentation, and a replay available about two hours later, will be accessible through the company’s investor relations website at ir.petco.com. The company also issued a press release dated August 21, 2025, which is included as an exhibit to this report.
On 1 Aug 2025, Petco Health & Wellness (WOOF) CEO/director Joel D. Anderson purchased 1,100 Class A shares at $2.48 through the company’s 2021 Employee Stock Purchase Plan, a transaction exempt under Rule 16b-3.
Post-purchase, Anderson’s direct stake is 3,226,281 shares, comprising 2,712,719 RSUs plus 513,562 unrestricted shares. He also reports indirect holdings of 853,304 shares (2020 Trust), 724,910 shares (2025 Trust) and 7,874 shares held by his son. No derivative securities were bought or sold.
The added shares increase his total beneficial ownership marginally—about 0.04 % of his direct position—but insider buys generally signal management confidence and may be viewed positively by investors.
Form 4 highlights: On 07/24/2025 Petco Health & Wellness (WOOF) director Rajendra M. Mohan received 43,422 restricted stock units (RSUs) under the 2021 Equity Incentive Plan. Each RSU converts into one Class A share; vesting occurs at the next annual shareholder meeting or by 07/24/2026, whichever comes first. The grant was recorded at $0 purchase price, a standard equity-compensation award.
Following the transaction, Mohan now reports 523,027 directly held Class A shares.
Notable disclosure: Since the last filing Mohan forfeited 631,914 time-based RSUs. Although this forfeiture is not treated as a same-day transaction, it materially reduced his reported beneficial ownership and more than offsets the new 43k-unit grant.
No derivative securities were acquired or disposed of, and there are no changes in indirect ownership.
Form 4 – Petco Health & Wellness (WOOF)
Director Gary S. Briggs reported the acquisition of 43,422 Restricted Stock Units on 24 Jul 2025. Each RSU represents one share of Class A common stock granted under the company’s 2021 Equity Incentive Plan at no cash cost.
The RSUs will vest on the earlier of Petco’s next annual shareholder meeting or 24 Jul 2026. Following this grant, Briggs directly owns 162,761 Class A shares. No shares were sold or otherwise disposed of, and no derivative securities beyond the RSUs were involved.
The filing reflects routine board equity compensation, marginally increasing insider ownership and aligning the director’s incentives with shareholder value.
Petco Health & Wellness Company (WOOF) – Form 4 filing, 28-Jul-2025
Director Iris Yen reported an acquisition (Code A) of 43,422 restricted stock units (RSUs) on 24-Jul-2025 under the company’s 2021 Equity Incentive Plan. Each RSU converts 1-for-1 into Class A common shares at no cost to the insider. The award vests on the earlier of the next annual shareholder meeting or 24-Jul-2026, encouraging one-year board-level alignment with shareholders.
Post-grant holdings:
- Direct: 145,787 Class A shares
- Indirect: 1,983 shares held via the Yen-Geniblazo Family Trust